Table 2.
Genotypes in Iranian HbH disease patients
| Mutation | Number (%) | Number (%) | Number (%) | Number (%) |
|---|---|---|---|---|
| 3.7/20.5 | 11 (22.4) | - | 4 (10) | 5 (8) |
| --MED/3.7 | 17 (34.6) | 4 (30.7) | 10 (25) | 21 (32) |
| --MED/C.S | 3 (6.1) | 2 (15.3) | 3 (7.5) | 4 (6) |
| 3.7/unknown | 3 (6.1) | |||
| 20.5/C.S | 1 (2.04) | 1 (2.5) | 3 (4.5) | |
| --MED/5nt | 1 (2.04) | 1 (2.5) | 1 (1.5) | |
| --MED/PolyA2 | 5 (10.2) | 2 (5) | 2 (3) | |
| 20.5/PolyA2 | 3 (6.1) | 2 (5) | 3 (4.5) | |
| --MED /21 bp del | 1 (2.04) | 2 (5) | 2 (3) | |
| --MED/IVSII+4-21ntlNS | 1 (2.04-)-- | |||
| 20.5/CD59 | 2 (4.08) | |||
| 20.5/CD99 | 1 (2.04) | 1 (1.5) | ||
| 5nt/20.5 | 6 (15) | 6 (9) | ||
| 3.7/C.S | 1 (7.69) | |||
| 3.7/T-Saudi | 2 (15.3) | |||
| --MED/T-Turkish | 1 (7.69) | |||
| T-Saudi Homo | 2 (15.3) | |||
| --MED/unknown | 1 (7.69) | |||
| --MED/4.2 | 1 (2.5) | 1 (1.5) | ||
| 3.7/CD19 | 1 (2.5) | |||
| PolyA2/PolyA2 | 3 (7.5) | |||
| PolyA1/PolyA1 | 3 (7.5) | 6 (9) | ||
| C.S/C.S | 1 (2.5) | 1 (1.5) | ||
| --MED/PolyA1 | 3 (4.5) | |||
| 3.7/CD19 | 3 (4.5) | |||
| CD59/--MED | 1 (1.5) | |||
| --MED/CD19 | 1 (1.5) | |||
| 3.7/PolyA1 | 1 (1.5) | |||
| αSun prairie/αSun prairie | 1 (1.5) | |||
| Ref | 48 | 49 | 50 | 51 |